Hikma Pharmaceuticals Share News (HIK)

Sector movers: GSK leads defensive pharma stocks higher

A massive cash return by Glaxosmithkline gave the wider sector a lift on Wednesday, with defensive healthcare and pharmaceutical stocks also benefiting from a reduction in risk appetite as UK markets pulled back from a five-month high. Sales, profits and earnings slumped during the fourth quarter of

UK BROKER RATINGS: Morgan Stanley Upgrades Barclays To Overweight

UK BROKER RATINGS: Bernstein Raises ITV And Sky To Outperform

MARKET COMMENT: London Closes Mixed As Oil Prices Resume Fall

BUZZ-Hikma Pharmaceuticals: life-high after appeal against co's drug fails

** Drugmaker's shares up 4.4 pct to life-high after Hikma says Takeda Pharmaceutical unsuccessful in appealing U.S. court decision to deny preliminary injunction of the Jordanian company's drug for gout flares. ** Hikma is the top gainer on the FTSE-350 Pharmaceuticals & Biotechnology index

UK WINNERS & LOSERS: Afren Plummets After Barda Rash Downgrade

UK MORNING BRIEFING: Shire Sets Out Ambitions With USD5.2 Billion Buy

Hikma Pharmaceuticals hiked by court colchicine ruling

A US court has given Hikma Pharmaceuticals permission to distribute its colchicine gout treatment, turning down rival Takeda Pharmaceuticals in its appeal for an injunction against the distribution of the drugs. The injunction, which was granted to Takeda on 9 October 2014, has been vacated followin

Hikma To Launch Cochicine Capsules After Takeda's Appeal Fails

FTSE 250 movers: Energy sector struggles as oil price continues to slide

Oil producers such as Afren and Premier Oil, and energy services firms Wood Group, Hunting and Petrofac, were all falling sharply on Monday as the price of oil continued to sink. Brent crude dropped below $55 a barrel (bbl) for the first time since May 2009. Afren was also continuing to decline afte

London midday: Resource stocks drag FTSE 100 into the red

UK stocks were trading firmly in the red by Monday lunchtime despite a positive start, with shares in the oil and mining sectors providing a drag. London's FTSE 100 was down 0.9% at 6,489 by midday, dropping sharply after reaching a high of 6,576.74 early on. This week will be the first full tradin

Hikma soars after bullish recommendation from brokers

Hikma Pharmaceuticals shares edged closer to an all-time high on Monday, in the wake of bullish recommendation from two brokers. The stock, which rose 66.8% in 2014, was among Europe's best performing small-cap after JP Morgan lifted its price target on Hikma shares by 18.4% and maintained an 'overw

BUZZ-Hikma: back near record highs, top-ranked brokers come out in favour

** Hikma Pharmaceuticals, up 3.7 pct and close to testing all-time high again after two 5-star rated brokers issue bullish recommendations on stock. ** Stock is Europe's best performing small-cap, extends 2014's stellar run that saw stock up 66.8 pct. ** JPMorgan lifts its PT on stock

Sector movers: Defensive pharma stocks fall as Santa Rally continues

Pharmaceutical and healthcare stocks were leading the fallers on Tuesday as investors dumped defensive assets amid a continued pre-Christmas rally. UK stocks have risen for six straight days as markets rebounded strongly following a recent sell-off. While more cyclical sectors such as construction

Thursday broker round-up

Aberdeen: Charles Stanley downgrades to 'hold'. Afren: Canaccord reduces target price from 115p to 65p, while staying with its 'speculative buy' recommendation. Amino Technologies: Northland moves target price from 120p to 130p and retains a 'buy' recommendation. Belgravium Technologies: WH Irelan